leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 23:48:19 - browse：3

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

WSS

MD Anderson's Padmanee Sharma responds to research credit suit

Biotech venture capitalists face new demands from investors

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Test for long Covid? Researchers find new clue in blood samples

Congress may force more Covid

MD Anderson's Padmanee Sharma responds to research credit suit

Wikipedia

leisure time

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Medicare Advantage enrollment hits roughly 33.4 million

Supreme Court strikes down use of affirmative action

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Guidelines to prevent youth baseball injuries need more muscle

New brain studies show LSD's effects on the brain in full color

Virginia high school admissions case could be legal follow

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

entertainment

Hospitals are piloting generative AI tools as regulators play catch

Think you might have Covid

Biotech venture capitalists face new demands from investors

Prior authorization will have to move faster under new Biden rule

Reporting on presidential health from Reagan to Trump and Biden

New brain studies show LSD's effects on the brain in full color

leisure time

hotspot

focus

Wikipedia